
Ask a doctor about a prescription for AMOXICILLIN/CLAVULANIC ACID AUROVITAS 875 mg/125 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Amoxicillin/Clavulanic Acid Aurovitas 875 mg/125 mg Film-Coated Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Amoxicillin/Clavulanic Acid Aurovitas is an antibiotic that eliminates the bacteria that cause infections. It contains two different drugs called amoxicillin and clavulanic acid. Amoxicillin belongs to a group of medicines known as "penicillins" which can sometimes lose their effectiveness (become inactivated). The other component (clavulanic acid) prevents this from happening.
Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or the common cold.
It is essential that you follow the instructions regarding dosage, administration interval, and treatment duration indicated by your doctor.
Do not store or reuse this medicine. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw medicines down the drain or into the trash.
Amoxicillin/Clavulanic Acid Aurovitas is used in children and adults to treat the following infections:
Do not take Amoxicillin/Clavulanic Acid Aurovitas:
→ Do not take Amoxicillin/Clavulanic Acid Aurovitas if you are in any of the above situations.
Before starting treatment with amoxicillin/clavulanic acid, if you are unsure, consult your doctor or pharmacist.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Amoxicillin/Clavulanic Acid Aurovitas if you:
If you are unsure whether any of the above symptoms affect you, inform your doctor or pharmacist before taking amoxicillin/clavulanic acid.
In some cases, your doctor may investigate the type of bacteria causing your infection. Depending on the results, you may be prescribed a different formulation of amoxicillin/clavulanic acid or another medicine.
Symptoms to be aware of
Amoxicillin/Clavulanic Acid Aurovitas can worsen existing conditions or cause severe side effects. These include allergic reactions, seizures, and inflammation of the large intestine. You should be aware of some symptoms while taking amoxicillin/clavulanic acid to reduce the risk of problems. See "Symptoms to be aware of" in section 4.
Blood and urine tests
If you are having blood tests (such as red blood cell status or liver function studies) or urine tests (to check glucose levels), inform your doctor or nurse that you are taking Amoxicillin/Clavulanic Acid Aurovitas. This is because amoxicillin/clavulanic acid can alter the results of these types of tests.
Other medicines and Amoxicillin/Clavulanic Acid Aurovitas
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
If you are taking allopurinol (used for gout) with amoxicillin/clavulanic acid, you may be more likely to suffer a skin allergic reaction.
Probenecid (used to treat gout), concomitant use of probenecid may reduce the excretion of amoxicillin and is not recommended.
If you are taking anticoagulants (such as warfarin) with amoxicillin/clavulanic acid, more frequent blood tests will be needed.
Methotrexate (a medicine used to treat cancer and severe psoriasis), penicillins may reduce the excretion of methotrexate and cause a potential increase in side effects.
Amoxicillin/Clavulanic Acid Aurovitas may affect how mycophenolate mofetil (a medicine used to prevent organ rejection after transplantation) works.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Consult your doctor or pharmacist before taking any medicine.
Driving and using machines
Amoxicillin/Clavulanic Acid Aurovitas may cause side effects that can affect your ability to drive or use machines. Do not drive or operate machinery unless you are feeling well.
Amoxicillin/Clavulanic Acid Aurovitas contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The recommended dose is:
Adults and children weighing 40 kg or more
Usual dose - 1 tablet administered twice a day.
Higher dose - 1 tablet administered three times a day.
Children weighing less than 40 kg
It is preferable to treat children aged 6 years or less with the oral suspension of amoxicillin/clavulanic acid or with sachets.
Consult your doctor or pharmacist when administering Amoxicillin/Clavulanic Acid Aurovitas tablets to children with a weight of less than 40 kg. The tablets are not suitable for children who weigh less than 25 kg.
Patients with kidney and liver problems
How to take Amoxicillin/Clavulanic Acid Aurovitas
If you take more Amoxicillin/Clavulanic Acid Aurovitas than you should
If you take too much Amoxicillin/Clavulanic Acid Aurovitas, you may experience symptoms such as stomach upset (nausea, vomiting, or diarrhea) or seizures. Consult your doctor as soon as possible. Take the pack with you to show the doctor.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Amoxicillin/Clavulanic Acid Aurovitas
If you forget to take a dose, take it as soon as you remember. Do not take the next dose too soon, wait at least 4 hours before taking the next dose. Do not take a double dose to make up for forgotten doses.
If you stop taking Amoxicillin/Clavulanic Acid Aurovitas
Continue taking Amoxicillin/Clavulanic Acid Aurovitas until you finish the treatment, even if you feel better. You need to take the full treatment to cure the infection. If some bacteria survive, they can cause the infection to come back.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The side effects listed below may occur with this medicine.
Symptoms to be aware of
Allergic reactions:
→ Contact your doctor immediatelyif you experience any of these symptoms. Stop taking Amoxicillin/Clavulanic Acid Aurovitas.
Inflammation of the large intestine
Inflammation of the large intestine, which causes watery diarrhea, usually with blood and mucus, stomach pain, and/or fever.
Acute inflammation of the pancreas (acute pancreatitis)
If you have severe and persistent stomach pain, this could be a sign of acute pancreatitis.
Drug-induced enterocolitis syndrome (DIES):
DIES has been reported mainly in children receiving amoxicillin/clavulanic acid. It is a certain type of allergic reaction with the main symptom of repeated vomiting (1-4 hours after taking the medicine). Other symptoms may include abdominal pain, lethargy, diarrhea, and low blood pressure.
→ Contact your doctor as soon as possiblefor advice if you have these symptoms.
Very common:
May affect more than 1 in 10 people.
Common:
May affect up to 1 in 10 people.
Uncommon:
May affect up to 1 in 100 people.
Uncommon side effects that may appear in your blood tests
Rare:
May affect up to 1 in 1,000 people.
→ If you have any of these symptoms, contact a doctor urgently.
Rare side effects that may appear in your blood or urine tests
Frequency not known
Cannot be estimated from the available data.
→ Contact a doctor immediately if you have any of these symptoms.
Side effects that may appear in your blood or urine tests:
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month stated.
This medicine does not require any special storage temperature.
Store in the original package to protect from light and moisture.
Do not use this medicine if you notice any change in the appearance of the tablets.
Medicines should not be disposed of via wastewater or household waste. Return the containers and any unused medicines to the pharmacy. If you are unsure, ask your pharmacist how to dispose of containers and unused medicines. This will help protect the environment.
Composition ofAmoxicillin/Clavulanic Acid Aurovitas
Each film-coated tablet contains amoxicillin trihydrate equivalent to 875 mg of amoxicillin and potassium clavulanate equivalent to 125 mg of clavulanic acid.
Core:microcrystalline cellulose (E460), anhydrous colloidal silica, magnesium stearate (E470b), sodium carboxymethyl starch (type A) (derived from potato starch).
Coating:hypromellose (E464) (5 CP & 15 CP), macrogol 400, titanium dioxide (E171).
Appearance of the Product and Container Content
Amoxicillin/Clavulanic Acid Aurovitas 875 mg/125 mg are film-coated tablets, capsule-shaped, white in color, engraved with "A" on one side and with a score line between the numbers "6" and "5" on the other. The score line is intended to facilitate breaking and swallowing, but not to divide into equal doses.
It is available in blister packs of 10, 14, 15, 16, 20, 21, 24, 30, and 500 film-coated tablets, and in a clinical pack of 20 film-coated tablets.
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Manufacturer:
APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
Or
Generis Farmacêutica, S.A.
Rua João de Deus, 19
2700-487 Amadora
Portugal
This Medicinal Product is Authorized in the Member States of the European Economic Area under the Following Names:
Germany Amoxi-Clavulan PUREN 875 mg/125 mg Filmtabletten
Spain Amoxicillin/Clavulanic Acid Aurovitas 875 mg/125 mg film-coated tablets EFG
Malta Amoxicillin/Clavulanic Acid Aurobindo 875 mg/125 mg film-coated tablets
Poland Amoxicillin+Clavulanic Acid Aurovitas
Portugal Amoxicillin + Clavulanic Acid Labesfal
Date of Last Revision of this Leaflet:October 2023
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)
Medical Advice/Education Antibiotics are used to treat infections caused by bacteria. They have no effect against infections caused by viruses. Sometimes, a bacterial infection does not respond to a course of an antibiotic. One of the most common reasons for this to happen is that the bacteria causing the infection are resistant to the antibiotic being taken. This means they can survive and even multiply despite the antibiotic. Bacteria can become resistant to antibiotics for many reasons. Careful use of antibiotics can help reduce the likelihood of bacteria becoming resistant to them. When your doctor prescribes an antibiotic treatment, it is only intended to treat your current illness. Paying attention to the following tips will help prevent the appearance of resistant bacteria that could stop the antibiotic from working.
|
The average price of AMOXICILLIN/CLAVULANIC ACID AUROVITAS 875 mg/125 mg FILM-COATED TABLETS in November, 2025 is around 6.81 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for AMOXICILLIN/CLAVULANIC ACID AUROVITAS 875 mg/125 mg FILM-COATED TABLETS – subject to medical assessment and local rules.